KPIs & Operating Metrics(New)
Growth Metrics

AbbVie (ABBV) Revenue (QoQ) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -9.72%
Dec 31, 2025 5.34%
Sep 30, 2025 2.29%
Jun 30, 2025 15.59%
Mar 31, 2025 -11.65%
Dec 31, 2024 4.44%
Sep 30, 2024 -0.01%
Jun 30, 2024 17.48%
Mar 31, 2024 -13.92%
Dec 31, 2023 2.69%
Sep 30, 2023 0.45%
Jun 30, 2023 13.42%
Mar 31, 2023 -19.15%
Dec 31, 2022 2.09%
Sep 30, 2022 1.57%
Jun 30, 2022 7.72%
Mar 31, 2022 -9.06%
Dec 31, 2021 3.79%
Sep 30, 2021 2.74%
Jun 30, 2021 7.29%
Mar 31, 2021 -6.12%
Dec 31, 2020 7.41%
Sep 30, 2020 23.76%
Jun 30, 2020 20.95%
Mar 31, 2020 -0.98%
Dec 31, 2019 2.65%
Sep 30, 2019 2.71%
Jun 30, 2019 5.45%
Mar 31, 2019 -5.74%
Dec 31, 2018 0.84%
Sep 30, 2018 -0.51%
Jun 30, 2018 4.34%
Mar 31, 2018 2.52%
Dec 31, 2017 10.64%
Sep 30, 2017 0.73%
Jun 30, 2017 6.21%
Mar 31, 2017 -3.80%
Dec 31, 2016 5.66%
Sep 30, 2016 -0.31%
Jun 30, 2016 8.29%
Mar 31, 2016 -6.91%
Dec 31, 2015 7.67%
Sep 30, 2015 5,455.14%
Jun 30, 2015 -97.88%
Mar 31, 2015 -7.56%
Dec 31, 2014 8.63%
Sep 30, 2014 1.89%
Jun 30, 2014 7.96%
Mar 31, 2014 -10.72%
Dec 31, 2013 9.73%
Sep 30, 2013 -0.72%
Jun 30, 2013 8.39%
Mar 31, 2013 -16.85%
Dec 31, 2012 15.48%
Sep 30, 2012 0.33%
Jun 30, 2012 7.67%